Angiotensin II Type 1 Receptor Blockers

DBCAT000409Pharmacologic class

Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. A DrugBank category of 11 drugs. 6 of them are approved.

Part of: Angiotensin II receptor antagonists
Also known as: Angiotensin 2 Type 1 Receptor Antagonists · Angiotensin II Type 1 Receptor Antagonists · Sartans · Selective Angiotensin II Receptor Antagonists · Type 1 Angiotensin Receptor Antagonists
Drugs: Allisartan isoproxil
Azilsartan medoxomil
Embusartan
Eprosartan
Forasartan
Losartan
Saprisartan
Sparsentan
Telmisartan
Valsartan
Zolasartan

What you can answer from here — as of February 04, 2021

11DrugsEach linked to its full drug card

Listed above

5Drug targetsEvery drug–target pair in the class, with bond type

10,385Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Angiotensin II Type 1 Receptor Blockers share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account